LAKE OSWEGO, Ore., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark Schwartz, Ph.D., will provide a presentation entitled, “New Horizons in Active Cancer Immunotherapy: Developing Cancer Vaccines” at the Cancer Targets and Therapeutics Conference. The presentation will take place on Tuesday, February 28, 2012 at 8:00 AM PST at the Red Rock Resort and Casino in Las Vegas, Nevada.
